Stockreport

Atai Beckley N.V. (ATAI) Receives Buy Rating on BPL-003 Edge against Spravato [Yahoo! Finance]

Atai Beckley N.V - Common Shares  (ATAI) 
US:NASDAQ Investor Relations: ir.atai.net.cn
PDF on Atai Beckley NV (NASDAQ:ATAI), pointing to encouraging clinical progress and solid financial footing. Positive Phase 2b results for BPL-003 in treatment-resistant dep [Read more]